ClinicalTrials.gg

Program

silicon dioxide

Also written as “Sodium fluoride / silica and carbopol, 1.5g”, “Colloidal Silicon Dioxide” and “Sodium fluoride / silica and carbopol, 0.5g”.

Its studies are mostly in Dermatitis, Atopic · Dental Caries · Dentin Sensitivity, led by 3 companies.

Furthest: phase 4, since Sep 26, 20083 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Colgate Palmolive10 open or runningphase 3since Sep 26, 2008Sep 26, 2008none ahead
GlaxoSmithKline10 open or runningphase 4since Feb 16, 2012Feb 16, 2012none ahead
Polisorb Joint Stock10 open or runningphase 3since Oct 20, 2026Oct 20, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Sep 26, 2008First study: phase 3 study in Dentin SensitivityNew to Colgate PalmoliveColgate Palmolive · NCT00763269 · 626 enrolled · United States
  2. Feb 16, 2012GlaxoSmithKline's first study: phase 4 study in Dental CariesNew to GlaxoSmithKlineGlaxoSmithKline · NCT01563172 · 65 enrolled · United States
  3. Oct 20, 2026Polisorb Joint Stock's first study: phase 3 study in Dermatitis, AtopicNew to Polisorb Joint StockPolisorb Joint Stock · NCT07929181 · 161 enrolled · Russia

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 3 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusLed byPrimary completionSize
NCT07929181Dermatitis, Atopic · Russia3CompletedPolisorb Joint StockNov 28, 2024161
NCT01563172Dental Caries · United States4CompletedGlaxoSmithKlineJun 1, 200965
NCT00763269Dentin Sensitivity · United States3CompletedColgate PalmoliveDec 2008626

How it is read

Names in the registry

  • “Sodium fluoride / silica and carbopol, 1.5g”, 2 entries
  • “Colloidal Silicon Dioxide”, 1 entry
  • “Sodium fluoride / silica and carbopol, 0.5g”, 1 entry
  • “Triclosan, Silicon dioxide, fluoride”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.